Media, Video 27 Jun 2021 Video | Stockhead Investor Presentation – June 2021 Orthocell CEO and Managing Director Paul Anderson spoke with Oriel Morrison as part of Stockhead V-Con Biotechs. Orthocell
Media, Video 22 Jun 2021 Video | Ticker News Interview – June 2021 Orthocell CEO and Managing Director, Paul Anderson, spoke with Ticker News about the positive findings from our CelGroâ„¢ clinical study. Orthocell
Media, Video 22 Jun 2021 Video | Proactive Investors – June 2021 Orthocell CEO and Managing Director Paul Anderson discusses with Proactive positive nerve regeneration results one year on from a study… Orthocell
Video 21 Jun 2021 Orthocell (ASX:OCC) demonstrates potential to return function to paralysed limbs Orthocell has been featured in The Market Herald, following the announcement of clinical data from the CelGro nerve regeneration trial… Orthocell
Media, Video 27 May 2021 Video | Proactive Investors – May 2021 Orthocell CEO and Managing Director Paul Anderson speaks to Proactive following the announcement newly granted patents for its CelGroâ„¢ collagen… Orthocell
Video 06 Jan 2021 Australia’s TGA approves Orthocell’s Celgroâ„¢ regenerative collagen medical device Orthocell CEO Paul Anderson spoke to BioWorld, following marketing clearance from Australia’s Therapeutic Goods Administration (TGA) for our Celgroâ„¢ collagen… Orthocell
Video 10 Nov 2020 HCP Webinar | Latest Developments in the Biological Treatment of Cartilage – Professor Martin Sullivan Professor Martin Sullivan Foot and Ankle Surgeon at St. Vincent’s Clinic & North Shore Private Hospital in Sydney presents 'An… Orthocell
Media, Video 22 Sep 2020 Video | Proactive Investors Interview – September 2020 Orthocell CEO and Managing Director Paul Anderson spoke with Andrew Scott from Proactive Investors about the company being in an… Orthocell
Video 22 May 2020 Australia’s Orthocell submits 510(k) for Celgroâ„¢ regenerative collagen medical device Orthocell has been featured in BioWorld, following the submission of a 510(k) application to the U.S. FDA for our Celgroâ„¢… Orthocell
Video 11 Mar 2020 Orthocell looks to enter US market following positive CelGro™ study results Small Caps has featured Orthocell's plans to enter the US market following the success of our Celgro™ dental implant study. Orthocell
